Materias dentro de su búsqueda.
Mostrando 5,041 - 5,060 Resultados de 5,950 Para Buscar 'Hanussen~', tiempo de consulta: 2.93s Limitar resultados
  1. 5041
    por Pálinkás, Anita, Sándor, János
    Publicado 2022
    “…Each vaccine could reduce the HVE-corrected all-cause mortality in the epidemic period (VE(Oxford/AstraZeneca) = 0.592 [0.518–0.655], VE(Janssen) = 0.754 [0.628–0.838], VE(Moderna) = 0.573 [0.526–0.615], VE(Pfizer-BioNTech) = 0.487 [0.461–0.513], VE(Sinopharm) = 0.530 [0.496–0.561], and VE(Sputnik) (V) = 0.557 [0.493–0.614]). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study
  2. 5042
    “…Booster vaccination increased with older age, with greater education, with higher income, among women, and among those stationed overseas; it decreased with previous COVID-19 infection and use of the Janssen vaccine. There were no significant racial or ethnic disparities in booster vaccination. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 Booster Vaccination in the U.S. Military, August 2021–January 2022
  3. 5043
    por Mucci, A., Giordano, G.M., Galderisi, S.
    Publicado 2022
    “…DISCLOSURE: Honoraria, advisory board, or consulting fees from Angelini, Astra Zeneca, Bristol-Myers Squibb, Gedeon Richter Bulgaria, Innova-Pharma, Janssen Pharmaceuticals, Lundbeck, Otsuka, Pfizer, and Pierre Fabre, for services not related to this abstract…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Recognition and Assessment of Cognitive Impairment in Schizophrenia
  4. 5044
    por Sánchez-Rivero, I.
    Publicado 2022
    “…DISCLOSURE: I received financing from Angelini Pharma, Casen Recordati, Janssen, Exeltis and Otsuka.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lurasidone in treatment of manic episode
  5. 5045
    “…DISCLOSURE: The author has received support from Janssen-Cilag, Otsuka-Lundbeck, Italfármaco, Angelini Pharma and Casen Recordati; and declares no support related to the subject of this article.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Neutropenia induced by Valproic Acid: A case report
  6. 5046
    “…The mRNA vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) elicit significantly higher serum IgG and neutralizing antibody levels than the adenoviral vector ChAdOx1 (AstraZeneca) and Ad26.COV2.S (Janssen) vaccines. However, all vaccines induce Spike- and RBD-specific Bmem, which are vital in providing long-lasting protection in the form of rapid recall responses to subsequent infections. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
  7. 5047
    “…METHODS: An observational cross-sectional study using data from the Brazilian surveillance information system to characterize the AE of COVID-19 vaccines (Sinovac/Butantan, Pfizer/BioNTech, AstraZeneca and Janssen) in Brazilian pregnant and postpartum women from April to August 2021. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Adverse events of COVID-19 vaccines in pregnant and postpartum women in Brazil: A cross-sectional study
  8. 5048
    “…The frequency of adverse events was higher for women than men, for Moderna than for Pfizer or Janssen, and for the first dose than for the second dose. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Analysis of COVID-19 vaccine adverse event using language model and unsupervised machine learning
  9. 5049
    por Barbui, Tiziano, Iurlo, Alessandra, Masciulli, Arianna, Carobbio, Alessandra, Ghirardi, Arianna, Carioli, Greta, Sobas, Marta, Elli, Elena Maria, Rumi, Elisa, De Stefano, Valerio, Lunghi, Francesca, Marchetti, Monia, Daffini, Rosa, Gasior Kabat, Mercedes, Cuevas, Beatriz, Fox, Laura Maria, Andrade, Marcio, Palandri, Francesca, Guglielmelli, Paola, Benevolo, Giulia, Harrison, Claire N., Foncillas, Maria Angeles, Bonifacio, Massimiliano, Alvarez-Larran, Alberto, Kiladjian, Jean-Jacques, Bolaños, Estefanía, Patriarca, Andrea, Quiroz, Keina, Griesshammer, Martin, Garcia Gutierrez, Valentín, Marin Sanchez, Alberto, Magro, Elena, Ruggeri, Marco, Hernandez Boluda, Juan Carlos, Osorio, Santiago, Carreño Gomez-Tarragona, Gonzalo, Sagüés, Miguel, Kusec, Rajko, Navas, Begoña, Angona, Anna, Xicoy, Blanca, Lopez Abadia, Emma, Koschmieder, Steffen, Cattaneo, Daniele, Bucelli, Cristina, Cichocka, Edyta, Masternak, Anna, Cavalca, Fabrizio, Borsani, Oscar, Betti, Silvia, Bellini, Marta, Curto-Garcia, Natalia, Rambaldi, Alessandro, Vannucchi, Alessandro
    Publicado 2021
    “…Benevolo:  Novartis: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Janssen: Membership on an entity's Board of Directors or advisory committees; Takeda: Membership on an entity's Board of Directors or advisory committees; BMS: Membership on an entity's Board of Directors or advisory committees; Amgen: Speakers Bureau. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Second Versus First Wave of COVID-19 in Patients with MPN
  10. 5050
    por Duval, Charles W., Couret, Maurice
    Publicado 1912
    “…The production of leprosy in the monkey proves conclusively that the acid-fast bacillus cultivated by one of us (Duval) from the human lesion is the Hansen bacillus and not some extraneous saprophyte, and that it is the etiological factor in human leprosy. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    A FURTHER NOTE UPON THE EXPERIMENTAL PRODUCTION OF LEPROSY IN THE MONKEY (MACACUS RHESUS), WITH A CRITICAL STUDY OF THE CULTURE EMPLOYED
  11. 5051
    “…Odenike:  Celgene, Incyte, AstraZeneca, Astex, NS Pharma, AbbVie, Gilead, Janssen, Oncotherapy, Agios, CTI/Baxalta, Aprea: Research Funding; AbbVie, Celgene, Impact Biomedicines, Novartis, Taiho Oncology, Takeda: Consultancy. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subgroup from the Ascertain Phase 3 Study
  12. 5052
    “…Odenike:  AbbVie, Celgene, Impact Biomedicines, Novartis, Taiho Oncology, Takeda: Consultancy; Celgene, Incyte, AstraZeneca, Astex, NS Pharma, AbbVie, Gilead, Janssen, Oncotherapy, Agios, CTI/Baxalta, Aprea: Research Funding. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Oral Decitabine/Cedazuridine in Patients with Lower Risk Myelodysplastic Syndrome: A Longer-Term Follow-up of from the Ascertain Study
  13. 5053
    “…Faust, FRCPCH PhD, AstraZeneca, Janssen, Pfizer, Moderna, GlaxoSmithKline, Novavax, Sanofi, Seqirus, Medimmune, Merck, MSD, Iliad and Valneva: Advisor/Consultant|AstraZeneca, Janssen, Pfizer, Moderna, GlaxoSmithKline, Novavax, Sanofi, Seqirus, Medimmune, Merck, MSD, Iliad and Valneva: Investigator Mark T. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    394. Consistency of AZD7442 (Cilgavimab/Tixagevimab) Pharmacokinetics Across Prophylaxis and Treatment and Adult and Pediatric Participants: Application of Population Pharmacokinetics to Enable Rapid Decision-Making During the COVID-19 Pandemic
  14. 5054
    “…Marcotullio, Abbvie, Gilead sciences, Janssen-Cilag: Scientific Advisor, Consulting fee and Research grant; B. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Patient Experience and Views on Antiretroviral Treatment—Findings from the Positive Perspectives Survey
  15. 5055
    “…Previously, we showed that all antipsychotics are related with body weight gain and there was a time effect, the longer the AP was taken the more the weight gain was (Bak, Fransen, Janssen, van Os, & Drukker, 2014). This study included data from 1999–2013. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    S2. ANTIPSYCHOTICS RESULT IN WEIGHT GAIN BUT THE SEVERITY OF WEIGHT GAIN DIFFERS BETWEEN ANTIPSYCHOTICS
  16. 5056
    “…Eron, MD, Gilead Sciences (Consultant, Research Grant or Support)Janssen (Consultant, Research Grant or Support)Merck (Consultant)ViiV (Consultant, Research Grant or Support) David A. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB2. Safety and Efficacy of Combination SARS-CoV-2 Monoclonal Neutralizing Antibodies (mAb) BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients
  17. 5057
    “…Connors:  Pfizer: Honoraria; CSL Behring: Research Funding; Alnylam: Consultancy; Bristol-Myers Squibb: Honoraria; takeda: Honoraria; Abbott: Consultancy. Rosovsky:  Janssen: Consultancy, Research Funding; BMS: Consultancy, Research Funding; Inari: Consultancy, Membership on an entity's Board of Directors or advisory committees; Dova: Consultancy, Membership on an entity's Board of Directors or advisory committees.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Bleeding Complications in Patients with Cancer and COVID 19- Analysis from the COVID 19and Cancer Consortium (CCC19) Registry
  18. 5058
    “…A partir de janeiro de 2021, foi iniciado a vacinação nos TAS: 70,9% vacinados com CoronaVac (Sinovac); 26,9% AstraZeneca; 0,2% Janssen; Pfizer 1,9% e 0,2% Janssen. A taxa de adesão à vacinação foi de 98,34%. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    IMPACTO DA VACINAÇÃO E DAS MEDIDAS DE PREVENÇÃO PARA COVID-19 EM TRABALHADORES DA ÁREA DA SAÚDE DE 12 HOSPITAIS DO ESTADO DE SÃO PAULO
  19. 5059
    “…This study aimed to investigate the efficacy, safety, and immunogenicity of the Ad26.COV2.S vaccine (Janssen) as primary vaccination plus a booster dose. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
  20. 5060
    “…Gill, PharmD, Everest Medicines, Shionogi, Cepheid: Grant/Research Support Matthew Gethers, PhD, Thermo Fisher: Employee Marco Falcone, MD, PhD, GILEAD: Grant/Research Support|GSK: Honoraria|MENARINI: Advisor/Consultant|MENARINI: Grant/Research Support|MSD: Honoraria|PFIZER: Honoraria|SHIONOGI: Grant/Research Support Francesco Menichetti, n/a, Aneglini: Advisor/Consultant|Aneglini: Board Member|Aneglini: Grant/Research Support|Aneglini: Honoraria|Astellas: Advisor/Consultant|Astellas: Honoraria|Becton: Advisor/Consultant|Becton: Honoraria|bioMérieux: Advisor/Consultant|bioMérieux: Honoraria|Biotest: Advisor/Consultant|Biotest: Board Member|Biotest: Honoraria|Bristol-Myers Squibb: Advisor/Consultant|Bristol-Myers Squibb: Honoraria|Correvio: Advisor/Consultant|Correvio: Speaker honoraria|Dickinson: Advisor/Consultant|Dickinson: Honoraria|Gilead: Advisor/Consultant|Gilead: Grant/Research Support|Janssen: Advisor/Consultant|Janssen: Honoraria|MSD: Advisor/Consultant|MSD: Speaker honoraria|Nordic pharma: Board Member|Nordic pharma: Honoraria|Pfizer: Advisor/Consultant|Pfizer: Honoraria|Shionogi: Advisor/Consultant|Shionogi: Honoraria|ViiV: Advisor/Consultant|ViiV: Honoraria David P. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1650. Efficacy of β-Lactam Therapy against Infections Caused by Metallo-β-lactamase (MBL)-Producing Enterobacterales: Bridging the Susceptibility Testing Gap
Herramientas de búsqueda: RSS